AISEMO
LIVE

Serial Number

79332496

Owner

AISEMO GmbH

Attorney

Victoria Friedman

Filing Date

Jul 16, 2021

Add to watchlist:

No watchlists yet
View on USPTO

AISEMO Trademark

Serial Number: 79332496 • Registration: 7021266

AISEMO is a trademark filed by AISEMO GmbH on July 16, 2021. The trademark is classified under Class 44 (Medical Services), Class 31 (Natural Agricultural Products). The application is currently registered and active.

Owner Contact Info

AISEMO GmbH (2 trademarks)

Jutogasse 3

Entity Type: 99

Trademark Details

Filing Date

July 16, 2021

Registration Date

April 11, 2023

Published for Opposition

January 24, 2023

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Aug 21, 2023 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jul 31, 2023 FICS
FINAL DISPOSITION PROCESSED
Jul 31, 2023 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jul 11, 2023 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Apr 11, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Apr 11, 2023 R.PR
NOTIFICATION PROCESSED BY IB
Jan 25, 2023 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 24, 2023 NPUB
PUBLISHED FOR OPPOSITION
Jan 24, 2023 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 4, 2023 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jan 4, 2023 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 4, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 21, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 22, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 22, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 22, 2022 TROA
REFUSAL PROCESSED BY IB
Jun 13, 2022 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
May 24, 2022 RFCS
REFUSAL PROCESSED BY MPU
May 24, 2022 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 14, 2022 RFCR
NON-FINAL ACTION WRITTEN
Apr 13, 2022 CNRT
ASSIGNED TO EXAMINER
Apr 7, 2022 DOCK
APPLICATION FILING RECEIPT MAILED
Feb 8, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 4, 2022 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Feb 3, 2022 REPR